Cognitive measures may improve with buntanetap in Parkinson’s
In people with early Parkinson’s disease, buntanetap slowed cognitive decline, with the biggest gains…
Articles by Andrea Lobo
$5M grant funds new strategy to clear Parkinson’s proteins
A $5 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) will help Booster Therapeutics develop…
Alector aims to seek FDA approval of Parkinson’s therapy in 2027
Alector said it is advancing the development of AL050, an enzyme replacement therapy for Parkinson’s disease, with an…
Trial testing light therapy device for Parkinson’s disease fully enrolled
Photopharmics has completed enrollment of a Phase 3 clinical trial testing Celeste, its light therapy device for Parkinson’s…
Jupiter’s oral resveratrol capsules cleared for testing in Parkinson’s
Jotrol, an oral formulation of the natural compound resveratrol, has been cleared for testing in people with Parkinson’s disease…
Women’s brains better protected from atrophy in REM disorder
Women with isolated REM sleep behavior disorder (iRBD), an early sign of Parkinson’s disease, exhibit fewer signs of early brain…
Study: Samples after death don’t accurately compare to living brains
Most molecular features in the human brain differ between samples obtained from living individuals and those collected after death, according…
New Parkinson’s drugs targeting apathy, falls, are advancing
Irlab Therapeutics has announced new advancements for its three symptoms-targeting Parkinson’s disease drugs — medications designed to treat…
NIH funds study to predict Parkinson’s risk with skin test
CND Life Sciences has been awarded a $3 million grant from the U.S. National Institutes of Health (NIH) to…
Kneu Health gets $5.6M for Parkinson’s symptom-tracking app
Kneu Health said it has raised $5.6 million to expand its smartphone-based platform that helps doctors monitor symptoms of…